Response to Editorial Comment to Impact of prior local therapy on overall survival in men with metastatic castration-resistant prostate cancer: Results from Shared Equal Access Regional Cancer Hospital

被引：0
|
作者：
Patel, Devin N. [1 ]
Chapin, Brian F. [2 ]
Freedland, Stephen J. [1 ,3 ]
机构：
[1] Cedars Sinai Med Ctr, Div Urol, Los Angeles, CA 90048 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Urol, Houston, TX 77030 USA
[3] Vet Affairs Med Ctr, Div Urol, Durham, NC 27705 USA
来源：
INTERNATIONAL JOURNAL OF UROLOGY | 2018年 / 25卷 / 12期
关键词：
D O I：
10.1111/iju.13861
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1005 / 1005
页数：1
相关论文
共 50 条
  • [41] Meta-Analysis Evaluating the Impact of Site of Metastasis on Overall Survival in Men With Castration-Resistant Prostate Cancer
    Halabi, Susan
    Kelly, William Kevin
    Ma, Hua
    Zhou, Haojin
    Solomon, Nicole C.
    Fizazi, Karim
    Tangen, Catherine M.
    Rosenthal, Mark
    Petrylak, Daniel P.
    Hussain, Maha
    Vogelzang, Nicholas J.
    Thompson, Ian M.
    Chi, Kim N.
    de Bono, Johann
    Armstrong, Andrew J.
    Eisenberger, Mario A.
    Fandi, Abderrahim
    Li, Shaoyi
    Araujo, John C.
    Logothetis, Christopher J.
    Quinn, David I.
    Morris, Michael J.
    Higano, Celestia S.
    Tannock, Ian F.
    Small, Eric J.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (14) : 1652 - U191
  • [42] Editorial Comment to Influence of prior oral ethinylestradiol use on the efficacy of enzalutamide for the treatment of castration-resistant prostate cancer in men
    Izumi, Kouji
    INTERNATIONAL JOURNAL OF UROLOGY, 2018, 25 (05) : 471 - 471
  • [43] Overall survival by race and ethnicity among men with metastatic castration-resistant prostate cancer (mCRPC) in the US Medicare population
    Freedland, Stephen J.
    Davis, Matthew
    Epstein, Andrew J.
    Arondekar, Bhakti
    Ivanova, Jasmina I.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (28) : 144 - 144
  • [44] External Validation of a Prognostic Model of Overall Survival in Men With Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer
    Halabi, Susan
    Yang, Qian
    Roy, Akash
    Luo, Bin
    Araujo, John C.
    Logothetis, Christopher
    Sternberg, Cora N.
    Armstrong, Andrew J.
    Carducci, Michael A.
    Chi, Kim N.
    de Bono, Johann S.
    Petrylak, Daniel P.
    Fizazi, Karim
    Higano, Celestia S.
    Morris, Michael J.
    Rathkopf, Dana E.
    Saad, Fred
    Ryan, Charles J.
    Small, Eric J.
    Kelly, William Kevin
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (15) : 2736 - +
  • [45] Overall and progression-free survival of Afro-Caribbean men with metastatic castration-resistant prostate cancer (mCRPC)
    Vestris, Pierre-Gilles
    Gourtaud, Gilles
    Senechal, Cedric
    Sadreux, Yvanne
    Roux, Virginie
    Blanchet, Pascal
    Brureau, Laurent
    PROSTATE, 2022, 82 (02): : 269 - 275
  • [46] Overall survival prediction in metastatic castration-resistant prostate cancer treated with radium-223
    Vidal, Monica
    Delgado, Alejandro
    Martinez, Carlos
    Jaime Correa, Jose
    Cristina Durango, Isabel
    INTERNATIONAL BRAZ J UROL, 2020, 46 (04): : 599 - 611
  • [47] Frailty and overall survival in metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamide.
    Deol, Ekamjit Singh
    Luo, Suhong
    Sanfilippo, Kristen Marie
    Eisen, Seth A.
    Schoen, Martin W.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [48] Prognostic models for predicting overall survival in metastatic castration-resistant prostate cancer: a systematic review
    Pinart, M.
    Kunath, F.
    Lieb, V.
    Tsaur, I.
    Wullich, B.
    Schmidt, Stefanie
    WORLD JOURNAL OF UROLOGY, 2020, 38 (03) : 613 - 635
  • [49] Prognostic models for predicting overall survival in metastatic castration-resistant prostate cancer: a systematic review
    M. Pinart
    F. Kunath
    V. Lieb
    I. Tsaur
    B. Wullich
    Stefanie Schmidt
    World Journal of Urology, 2020, 38 : 613 - 635
  • [50] Bipolar androgen therapy plus olaparib in men with metastatic castration-resistant prostate cancer
    Michael T. Schweizer
    Roman Gulati
    Todd Yezefski
    Heather H. Cheng
    Elahe Mostaghel
    Michael C. Haffner
    Radhika A. Patel
    Navonil De Sarkar
    Gavin Ha
    Ruth Dumpit
    Brianna Woo
    Aaron Lin
    Patrick Panlasigui
    Nerina McDonald
    Michael Lai
    Katie Nega
    Jeannette Hammond
    Petros Grivas
    Andrew Hsieh
    Bruce Montgomery
    Peter S. Nelson
    Evan Y. Yu
    Prostate Cancer and Prostatic Diseases, 2023, 26 : 194 - 200
12345